NCT03100734View on ClinicalTrials.gov

Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel

CompletedOBSERVATIONAL
Enrollment

585

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Rheumatoid ArthritisAxial Spondyloarthritis
Interventions
BIOLOGICAL

Benepali

As specified in the treatment arm

BIOLOGICAL

Enbrel

As specified in the treatment arm

Trial Locations (1)

80639

Research Site, München

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
collaborator

Samsung Bioepis Co., Ltd.

INDUSTRY

lead

Biogen

INDUSTRY